Literature DB >> 14531821

Glucose degradation products (GDP) retard remesothelialization independently of D-glucose concentration.

Llinos W Morgan1, Anders Wieslander, Malcolm Davies, Takashi Horiuchi, Yuji Ohta, M Janine Beavis, Kathryn J Craig, John D Williams, Nicholas Topley.   

Abstract

BACKGROUND: Glucose degradation products (GDP) present in heat-sterilized dialysis fluids are thought to contribute to cellular dysfunction and membrane damage during peritoneal dialysis. To examine the effects of specific GDP on the remesothelialization process, the impact of conventional and low GDP peritoneal dialysis solutions, D-glucose, and individual GDP in a scratch-wounding model was assessed.
METHODS: Scratch (0.5 to 0.6 mm)-wounded human peritoneal mesothelial cells (HPMC) were treated, at pH 7.4, with either (1) control medium (M199), (2) laboratory-prepared heat or filter-sterilized solutions, (3) 10% to 80% vol/vol solution of Gambrosol or Gambrosol-trio (1.5% and 4.0% glucose), (4) D-glucose (5 to 80 mmol/L), or (5) individual or combined GDP [acetaldehyde, formaldehyde, glyoxal, methylglyoxal, 3-deoxyglucosone (3-DG), 5-hydroxy methylfufural (5-HMF), or 3,4-di-deoxyglucosone-3-ene (3,4-DGE)]. Wound closure was recorded by time-lapse photomicroscopy.
RESULTS: In untreated HPMC, the rate of wound closure was linear and the process was complete by 18.4 +/- 3.6 hours (N = 16). In wounded HPMC exposed to dilutions of heat-sterilized but not filtered laboratory solutions (1.5% or 4.0% glucose, pH 7.4), remesothelialization was significantly retarded (P = 0.04 and P = 0.009 vs. M199, respectively). In Gambrosol, remesothelialization was significantly retarded in both 1.5% and 4.0% solutions. In contrast in Gambrosol-trio-treated HPMC, this rate was not significantly reduced in either 1.5% or 4.0% glucose peritoneal dialysis fluids. Remesothelialization was dose-dependently retarded in HPMC exposed to 3,4-DGE (>10 microl/L), formaldehyde (>5 micromol/L) but not by exposure to the other GDP tested even at 5 times the concentration present in low glucose solutions. The rate of remesothelialization was not significantly altered by exposure to D-glucose concentrations up to 80 mmol/L.
CONCLUSION: These data identify that the formaldehyde and 3,4-DGE present in heat-sterilized peritoneal dialysis solutions are important in reducing mesothelial cell regeneration. Specifically targeting their removal may have major benefits in preserving the mesothelium during long-term peritoneal dialysis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14531821     DOI: 10.1046/j.1523-1755.2003.00265.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  23 in total

Review 1.  Glucose degradation products (GDP's) and peritoneal changes in patients on chronic peritoneal dialysis: will new dialysis solutions prevent these changes?

Authors:  Murali Krishnan; Paul Tam; George Wu; Andrzej Breborowicz; Dimitrios G Oreopoulos
Journal:  Int Urol Nephrol       Date:  2005       Impact factor: 2.370

2.  Intercellular localization of occludins and ZO-1 as a solute transport barrier of the mesothelial monolayer.

Authors:  Ken-ichi Kaneda; Keiichi Miyamoto; Shinsuke Nomura; Takashi Horiuchi
Journal:  J Artif Organs       Date:  2006-12-21       Impact factor: 1.731

Review 3.  An update on peritoneal dialysis solutions.

Authors:  Elvia García-López; Bengt Lindholm; Simon Davies
Journal:  Nat Rev Nephrol       Date:  2012-02-21       Impact factor: 28.314

4.  Biocompatibility of a new PD solution for Japan, Reguneal™, measured as in vitro proliferation of fibroblasts.

Authors:  Bart Dioos; Goedele Paternot; Rose-Marie Jenvert; Annick Duponchelle; Mark R Marshall; Migaku Nakajima; Edward Ramirez Ganoza; James A Sloand; Anders P Wieslander
Journal:  Clin Exp Nephrol       Date:  2018-06-20       Impact factor: 2.801

5.  Peritoneal morphology after long-term peritoneal dialysis with biocompatible fluid: recent clinical practice in Japan.

Authors:  Nobuhiro Ayuzawa; Yoshitaka Ishibashi; Yutaka Takazawa; Haruki Kume; Toshiro Fujita
Journal:  Perit Dial Int       Date:  2011-07-31       Impact factor: 1.756

6.  A peritoneal dialysis regimen low in glucose and glucose degradation products results in increased cancer antigen 125 and peritoneal activation.

Authors:  Caatje Y le Poole; Angelique G A Welten; Piet M ter Wee; Nanne J Paauw; Amina N Djorai; Rob M Valentijn; Robert H J Beelen; Jacob van den Born; Frans J van Ittersum
Journal:  Perit Dial Int       Date:  2011-11-01       Impact factor: 1.756

7.  Impact of 3,4-dideoxyglucosone-3-ene (3,4-DGE) on cytotoxicity of acidic heat-sterilized peritoneal dialysis fluid.

Authors:  Tadashi Tomo; Eiji Okabe; Takashi Yamamoto; Shinji Namoto; Tomohiko Iwashita; Kazuhiro Matsuyama; Jun-ichi Kadota
Journal:  J Artif Organs       Date:  2007-03-23       Impact factor: 1.731

8.  Infusion fluids contain harmful glucose degradation products.

Authors:  Anna Bryland; Marcus Broman; Martin Erixon; Bengt Klarin; Torbjörn Lindén; Hans Friberg; Anders Wieslander; Per Kjellstrand; Claudio Ronco; Ola Carlsson; Gabriela Godaly
Journal:  Intensive Care Med       Date:  2010-04-16       Impact factor: 17.440

9.  Hyperbranched polyglycerol is an efficacious and biocompatible novel osmotic agent in a rodent model of peritoneal dialysis.

Authors:  Asher A Mendelson; Qiunong Guan; Irina Chafeeva; Gerald A da Roza; Jayachandran N Kizhakkedathu; Caigan Du
Journal:  Perit Dial Int       Date:  2013 Jan-Feb       Impact factor: 1.756

10.  Interference of peritoneal dialysis fluids with cell cycle mechanisms.

Authors:  Janine Büchel; Maria Bartosova; Gwendolyn Eich; Timo Wittenberger; Ludger Klein-Hitpass; Sonja Steppan; Thilo Hackert; Franz Schaefer; Jutta Passlick-Deetjen; Claus P Schmitt
Journal:  Perit Dial Int       Date:  2014-07-31       Impact factor: 1.756

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.